LSAE Publication Sources Tool

Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN), Ministry of Public Health (Congo, DR), World Health Organization Regional Office for Africa (WHO-AFRO). Democratic Republic of the Congo Lymphatic Filariasis Site Level Map Data 1946-2015. Brazzaville, Congo: World Health Organization Regional Office for Africa (WHO-AFRO), 2018.

Graves PM, Sheridan S, Fuimaono S, Lau CL. Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014. Parasites Vectors. 2020; 13(1): 125.

Gyapong JO, Adjei S, Sackey SO. Descriptive epidemiology of lymphatic filariasis in Ghana. Trans R Soc Trop Med Hyg. 1996; 90(1): 26-30.

Lau CL, Sheridan S, Ryan S, Roineau M, Andreosso A, Fuimaono S, Tufa J, Graves PM. Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration. PLoS Negl Trop Dis. 2017; 11(9): e0005914.

Torres EP, Ramirez BL, Salazar F, Pasay MC, Alamares JG, Santiago ML, Hafalla JC. Detection of bancroftian filariasis in human blood samples from Sorsogon province, the Philippines by polymerase chain reaction. Parasitol Res. 2001; 87(8): 677-9.

Fischer P, Supali T, Wibowo H, Bonow I, Williams SA. Detection of DNA of nocturnally periodic Brugia malayi in night and day blood samples by a polymerase chain reaction-ELISA-based method using an internal control DNA. Am J Trop Med Hyg. 2000; 62(2): 291-6.

Ramesh A, Cameron M, Spence K, Hoek Spaans R, Melo-Santos MAV, Paiva MHS, Guedes DRD, Barbosa RMR, Oliveira CMF, Sá A, Jeffries CL, Castanha PMS, Oliveira PAS, Walker T, Alexander N, Braga C. Development of an urban molecular xenomonitoring system for lymphatic filariasis in the Recife Metropolitan Region, Brazil. PLoS Negl Trop Dis. 2018; 12(10): e0006816.

Schuurkamp GJ, Kereu RK, Bulungol PK, Kawereng A, Spicer PE. Diethylcarbamazine in the control of bancroftian filariasis in the Ok Tedi area of Papua New Guinea: phase 2--annual single-dose treatment. P N G Med J. 1994; 37(2): 65-81.

Rosanti TI, Mardihusodo SJ, Artama WT. Directly observed treatment increases drug compliance in lymphatic filariasis mass drug administration. Univers Medicina. 2016; 35(2): 119-27.

Sapak P, Valley A, Giurina P, Maibani C. Diurnal sub-periodic Bancroftian filariasis in Dogura, Papua New Guinea. Pac Health Dialog. 1998; 5(1): 38-40.

Coulibaly YI, Coulibaly SY, Dolo H, Konate S, Diallo AA, Doumbia SS, Soumaoro L, Coulibaly ME, Dicko I, Sangare MB, Dembele B, Sangare M, Dembele M, Touré YT, Kelly-Hope L, Polman K, Kyelem D, Traore SF, Bockarie M, Klion AD, Nutman TB. Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali. Parasites Vectors. 2016; 9(1): 628.

Ramaiah KD, Vanamail P, Yuvaraj J, Das PK. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Trans R Soc Trop Med Hyg. 2011; 105(8): 431-7.

Mukhopadhyay AK, Patnaik SK. Effect of mass drug administration programme on microfilaria carriers in East Godavari district of Andhra Pradesh. J Vector Borne Dis. 2007; 44(4): 277-80.

Ramzy RMR, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet. 2006; 367(9515): 992-9.

Mataika JU, Kimura E, Koroivueta J, Shimada M. Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji. Bull World Health Organ. 1998; 76(6): 575-9.

Bockarie MJ, Tavul L, Ibam I, Kastens W, Hazlett F, Tisch DJ, Alpers MP, Kazura JW. Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. Am J Trop Med Hyg. 2007; 76(1): 62-6.

Wanji S, Tendongfor N, Esum M, Che JN, Mand S, Tanga Mbi C, Enyong P, Hoerauf A. Elephantiasis of non-filarial origin (podoconiosis) in the highlands of north-western Cameroon. Ann Trop Med Parasitol. 2008; 102(6): 529–40.

Schlemper BR Jr, Steindel M, Grisard EC, Carvalho-Pinto CJ, Bernardini OJ, de Castilho CV, Rosa G, Kilian S, Guarneri AA, Rocha A, Medeiros Z, Ferreira Neto JA. Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina state, Brazil. Trop Med Int Health. 2000; 5(12): 848-54.

Ramzy RMR, Kamal HA, Hassan MA, Haggag AA. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt. Acta Trop. 2019; 199: 105121.

Ave C, Kapa DR, Ottesen E. Elimination of lymphatic filariasis as a public health problem from the Cook Islands. Trop Med Health. 2018; 46: 12.

Ofanoa R, Ofa T, Padmasiri EA, Kapa DR. Elimination of lymphatic filariasis as a public health problem from Tonga. Trop Med Health. 2019; 47: 43.

Srivastava PK, Krishnamoorthy K, Govenkar S, Perni S, Dalvi S, Subramanain S, Dhariwal AC, Bhattacharjee J, Dash AP. Elimination of lymphatic filariasis in goa: First successful transmission assessment survey in India. J Commun Dis. 2014; 46(2): 7-16.

Rebollo MP, Sambou SM, Thomas B, Biritwum NK, Jaye MC, Kelly-Hope L, Escalada AG, Molyneux DH, Bockarie MJ. Elimination of lymphatic filariasis in the Gambia. PLoS Negl Trop Dis. 2015; 9.0(3): e0003642.

Minetti C, Tettevi EJ, Mechan F, Prada JM, Idun B, Biritwum NK, Osei-Atweneboana MY, Reimer LJ. Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana. PLoS Negl Trop Dis. 2019; 13(1): e0006994.

Chand G, Barde PV, Singh N. Emergence of new foci of filariasis in Madhya Pradesh, India. Trans R Soc Trop Med Hyg. 2013; 107(7): 462-4.